Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor
Authors:
- Eric D. DonnenfeldEDEric D. Donnenfeld
- Henry D. PerryHPHenry D. Perry
- Jonathan SteinJSJonathan Stein
- Adam BloomABAdam Bloom
- 1 March 2005
- journal article
- clinical trial
- Published by Elsevier in Ophthalmology
- Vol. 112 (3) , 466-469
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolatesAmerican Journal of Ophthalmology, 2003
- Recent Advances and Future Frontiers in Treating Age-Related CataractsJAMA, 2003
- Fluoroquinolone therapy in multiple-drug resistant staphylococcal keratitis after lamellar keratectomy in a rabbit modelAmerican Journal of Ophthalmology, 2003
- Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibioticsAmerican Journal of Ophthalmology, 2002
- Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variantsInternational Journal of Antimicrobial Agents, 2001
- FluoroquinolonesDrugs, 2001
- Shifting trends in bacterial keratitis in South Florida and emerging resistance to fluoroquinolonesOphthalmology, 2000
- Emerging ciprofloxacin-resistant Pseudomonas aeruginosaAmerican Journal of Ophthalmology, 1999
- Mechanisms of fluoroquinolone resistanceDrug Resistance Updates, 1999
- Results of the Endophthalmitis Vitrectomy StudyArchives of Ophthalmology (1950), 1995